Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Convenience Sampling Method00:55

Convenience Sampling Method

Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. Data are the result of sampling from a population. The sampling method ensures that samples are drawn without bias and accurately represent the population.
Convenience sampling is a non-random method of sample selection; this method selects individuals that are easily accessible and may result in biased data. For example, a marketing...
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-ray Crystallography-Guided Design and Synthesis of Cyclopentyl Heteroaryl Carboxylic Acid-Based Inhibitors of the SARS-CoV-2 Nsp3 Macrodomain (Mac1).

Journal of medicinal chemistry·2026
Same author

Expediated synthesis of <i>N</i>-acyl-<i>N</i>-alkyl sulfonamide probes for protein proximity labelling.

Organic & biomolecular chemistry·2026
Same author

Towards all optically powered miniature devices in remote locations of the body.

Optics letters·2026
Same author

Design, modular synthesis and screening of 58 shape-diverse 3-D fragments.

Chemical science·2025
Same author

Patients' Priorities and Goals of Care During Intensive Care Unit Recovery: A Multicenter Cohort Study.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2025
Same author

Synthesis of a macrocyclic and medium-sized ring lactam library using cascade ring expansion reactions.

Organic & biomolecular chemistry·2025

Related Experiment Video

Updated: Jun 29, 2026

Taste Exam: A Brief and Validated Test
07:10

Taste Exam: A Brief and Validated Test

Published on: August 17, 2018

A readily-accessible (+)-sparteine surrogate.

Michael J Dearden1, Catherine R Firkin, Jean-Paul R Hermet

  • 1Department of Chemistry, University of York, Heslington, York YO10 5DD, U.K.

Journal of the American Chemical Society
|October 3, 2002
PubMed
Summary

A novel chiral diamine, synthesized from (-)-cytisine, shows enantiocomplementary selectivity to (-)-sparteine in asymmetric transformations. This finding offers new possibilities for chiral synthesis and catalyst development.

More Related Videos

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays
15:04

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

Published on: November 2, 2019

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli
06:56

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli

Published on: March 24, 2023

Related Experiment Videos

Last Updated: Jun 29, 2026

Taste Exam: A Brief and Validated Test
07:10

Taste Exam: A Brief and Validated Test

Published on: August 17, 2018

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays
15:04

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

Published on: November 2, 2019

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli
06:56

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli

Published on: March 24, 2023

Area of Science:

  • Organic Chemistry
  • Asymmetric Synthesis
  • Catalysis

Background:

  • Chiral diamines are crucial ligands in asymmetric catalysis.
  • (-)-Sparteine is a well-established chiral diamine ligand.
  • Developing new chiral ligands with complementary selectivity is of significant interest.

Purpose of the Study:

  • To synthesize a novel chiral diamine derived from (-)-cytisine.
  • To evaluate the performance of this new diamine in asymmetric transformations.
  • To compare its enantioselectivity with that of (-)-sparteine.

Main Methods:

  • Three-step synthesis of the target chiral diamine from (-)-cytisine.
  • Evaluation in four distinct asymmetric transformations.
  • Analysis of enantioselectivity and comparison with (-)-sparteine.

Main Results:

  • The novel chiral diamine was successfully synthesized.
  • It exhibited high enantioselectivity in all tested asymmetric reactions.
  • The observed selectivity was enantiocomplementary to that of (-)-sparteine.

Conclusions:

  • The new chiral diamine is a viable alternative to (-)-sparteine.
  • It provides access to the opposite enantiomer in asymmetric synthesis.
  • This research expands the toolkit for asymmetric catalysis.